Protalix BioTherapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Protalix BioTherapeutics, Inc.
CIK #0001006281
EDGAR Form CIK 2011 - 2024
10-K [0001006281]
10-Q [0001006281]
3 [0001006281]
4 [0001006281]
8-K [0001006281]
SC 13G [0001006281]
Form 13D/13G Filer Form 13D/13G Subject Filed
Whitebox Advisors LLC Protalix Biotherapeutics Inc [2022-06-09]
Burrage Capital Management LLC Protalix Biotherapeutics Inc [2021-02-12]
Nacht Marius Protalix Biotherapeutics Inc [2020-11-24]
Akirov Alfred Protalix Biotherapeutics Inc [2020-03-30]
Dexcel Pharma Technologies Ltd Protalix Biotherapeutics Inc [2020-03-25]
Highbridge Capital Management LLC Protalix Biotherapeutics Inc [2020-03-23]
Citigroup Inc Protalix Biotherapeutics Inc [2018-02-09]
Highbridge Capital Management LLC Protalix Biotherapeutics Inc [2016-12-23]
Opaleye Management Inc Protalix Biotherapeutics Inc [2015-11-23]
Pfizer Inc Protalix Biotherapeutics Inc [2015-10-23]
View All
Form 3/4/5 Subject 2011 - 2024
Naos Yaron
Protalix BioTherapeutics, Inc.
Rubin Eyal
Bashan Dror
Melincoff Gwen A
Boudes Pol F
Schwartz Aharon
Bar-Shalev Amos
Ben Zvi Shmuel
Forster Eliot
View All
Terms | Privacy | Guide
tony@aum13f.com